November 5, 2013, China Pioneer Pharma Holdings Limited (“Pioneer Pharma”) successfully launched its initial public offering for a Hong Kong Stock Exchange main board listing under the stock code of 01345. The company globally issued 333,334,000 shares priced at HKD 4.1 per share, raising approximately HKD 1.294 billion in total.

The company principally provides marketing, promotion and channel management service of imported pharmaceutical products and medical devices.

Jingtian & Gongcheng acted as the issuer’s PRC legal counsel.